Health Trials

Penile Squamous Cell Carcinoma

2

Review clinical trials related to Penile Squamous Cell Carcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

The goal of this study is to evaluate the safety and effectiveness of EVOLVE104 in participants with advanced urothelial and squamous cell carcinomas who have previously taken standard treatment options, have declined or have been ineligible for treatment with these medications. Participants with advanced or metastatic cancer who meet all eligibility criteria may be eligible to participate in the study.

Participants needed: 160
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: EvolveImmune United, IncUpdated: Jul 2, 2026Locations: 12
Eligibility criteria

Participant must have documented disease progression during or post treatment wi... [+6]

The participant is a candidate for treatment with a targeted agent known to prov... [+12]

Read more
Status: Recruiting

Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer

This is a single-armed, single-centre, non-blinded phase II trial to assess efficacy of induction chemo-immunotherapy for resectable node-positive squamous cell carcinoma of the penis

Participants needed: 27
Trial details
Phase: Phase 2Age: 18+Biological sex: MaleType: InterventionalSponsor: The Netherlands Cancer InstituteUpdated: Dec 8, 2025Locations: 2
Eligibility criteria

The participant (or legally acceptable representative if applicable) provides wr... [+8]

Has received prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2 agent or... [+18]

Read more